Lavipharm S.A (LAVI) — Capital Reinvestment Ratio
Lavipharm S.A (LAVI) has a Capital Reinvestment Ratio of 33.32x as of December 2022, meaning it reinvests 33% of its operating cash flow (€527.00K) in capital expenditures (€17.56 Million). See Lavipharm S.A balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Lavipharm S.A Capital Reinvestment Ratio (2014–2024)
This chart tracks Lavipharm S.A's Capital Reinvestment Ratio across 11 annual periods. Check cash flow reinvestment rate of Lavipharm S.A to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Lavipharm S.A (2014–2024)
Year-by-year Capital Reinvestment Ratio for Lavipharm S.A from 2014 to 2024. For live market cap and broader valuation context, see how much is Lavipharm S.A worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.08x | €4.64 Million | €9.64 Million | ▼ -85.4% |
| 2023 | 14.26x | €284.00K | €4.05 Million | ▲ +34.0% |
| 2022 | 10.64x | €3.35 Million | €35.62 Million | ▲ +2020.0% |
| 2021 | 0.50x | €3.82 Million | €1.92 Million | ▼ -3.1% |
| 2020 | 0.52x | €2.85 Million | €1.48 Million | ▼ -38.0% |
| 2019 | 0.84x | €2.89 Million | €2.42 Million | ▲ +14.7% |
| 2018 | 0.73x | €1.42 Million | €1.03 Million | ▲ +215.0% |
| 2017 | 0.23x | €1.51 Million | €350.00K | ▲ +44.4% |
| 2016 | 0.16x | €606.00K | €97.00K | ▲ +300.9% |
| 2015 | 0.04x | €576.00K | €23.00K | ▼ -92.1% |
| 2014 | 0.51x | €2.38 Million | €1.20 Million | — |